In contrast to Neurofilament Light Chain (NFL), a promising biomarker for neurodegeneration increasingly used in MS whose serum levels correlate well with CSF levels, it is unclear whether BDNF levels in serum reflect those in CSF (57). This evidence concerns the gene BDNF and myeloid sarcoma.